Quidel | QDEL - Cash And Equivalent


Quidel reported $123.4M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Agilent USD 1.81B 49M Mar/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 192.02M 195K Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Haemonetics USD 223.38M 22.06M Jun/2026
Illumina USD 1.09B 329M Mar/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Pacific Biosciences Of California USD 61M 4.73M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
STAAR Surgical USD 148.58M 16.72M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 539M 77M Jun/2026